Related Experiment Videos
Prophylactic use of cefotaxime in elective biliary surgery
The Journal of Antimicrobial Chemotherapy
|September 1, 1984
Summary
Prophylactic cefotaxime significantly reduced surgical site infections in patients undergoing biliary surgery. This antibiotic intervention prevented all infections in the treated group, unlike the untreated control group.
Area of Science:
- Surgical Oncology
- Infectious Disease Prevention
- Clinical Pharmacology
Background:
- Biliary surgery poses a risk of surgical site infections (SSIs).
- Antibiotic prophylaxis is a key strategy in preventing SSIs.
- Evaluating specific antibiotic efficacy in biliary surgery is crucial.
Purpose of the Study:
- To assess the efficacy of cefotaxime prophylaxis in preventing wound infections after elective biliary surgery.
- To compare infection rates between patients receiving cefotaxime and those receiving no prophylactic treatment.
Main Methods:
- A randomized trial involving 66 patients undergoing elective biliary surgery.
- One group received 1g intravenous cefotaxime at anesthesia induction.
- The control group received no antibiotic prophylaxis.
Main Results:
- A 12.5% wound infection rate was observed in the untreated group.
- No wound infections occurred in the group treated with cefotaxime.
- Cefotaxime demonstrated complete efficacy in preventing infections in this cohort.
Conclusions:
- Intravenous cefotaxime administered at induction is highly effective in preventing surgical site infections in elective biliary surgery.
- Cefotaxime prophylaxis represents a valuable strategy for improving patient outcomes in biliary procedures.
- The findings support the routine use of cefotaxime for SSI prevention in this surgical setting.